Corporate Fact Sheet
Our clear competitive advantage comes from the combination of our deep domain knowledge, enterprise standard technology solutions and our global presence. We foster a customer centric corporate culture with a focus on innovation. We are an established solutions provider with dependable partners and marquee customers. We have successfully provided solutions to twelve of the world’s leading pharmaceutical companies, premier anatomic pathology research laboratories and institutions worldwide.
Background
- 4 years old, California Corporation with 85 people including India Development center
- Experienced Management team with successful track record
- Good Board, Advisory Board & Investors
- Successfully acquired & integrated Scimagix & Tissue Informatics
- Strategic Partnership with OSU Pathology Department, HP, Oracle
- Innovative technology with a sustainable competitive advantage
- Serving 2 Markets:
- Research: BioPharma
- Clinical : Cancer Diagnostics
Key Differentiator:
- Proprietary technology with 16 patents filed and FDA clearance
- Complete Solution, Software, System & Instrument
- Lowest cost platform with pay per use business model for rapid adoption
- Marquee customers: US Labs, UCSF, NCI, AFIP, Pfizer, Roche and Bristol Meyers
Mission
To provide enable affordable comprehensive digital pathology solutions ( DP) for every pathologist in every hospital and laboratory worldwide
Our Business
To provide total digital pathology solutions for clinical laboratories diagnostics and drug discovery, using innovations in technology and bio sciences
BioImagene’s digital pathology solution
Fully integrated hardware and software systems to acquire, view, analyze, manage, archive and share tissue images in a pathology laboratory
Customers
Leading Reference Labs, Clinicians, Pharmaceutical companies in US.
BioImagene, Inc.
- Founded in Jan 2003, HQ in California Silicon Valley, with software development and research center in Pune, India need number of people and amount invested
- Acquired Scimagix Inc, leader in Image Management in Nov 2004
- Increased breadth and depth of technology
- Acquired TissueInformatics Inc, leader in toxicological image analysis in June 2006
- By 2006 BI had 12 of top 20 Pharma/Biotech, 1000+ pharma and clinical users
BioImagene Today
- Team of 75 professionals globally located
- Experienced management team and board of directors
- Collaboration with leading universities and technology thought leaders
- Focus : To provide a comprehensive product offering to our customers – the total
Digital Pathology (DP) Solution
- Analytical software, scanner, and services
- Strong IP with 14 patents filed
- Customer focus Markets: BioPharma and Cancer Diagnostics
BioImagene’s Value Proposition
- ONLY company with total solution
- Scanner
- Comprehensive application software
- FDA-cleared analysis protocol
- Unique Pricing to improve pathologists’ revenues
- ZERO upfront cost
- ONLY company with pay-per-use recurrent revenue model
- Scanner
- High value, high quality and high capacity
- Image analysis
- 30+ protocols & growing
- Extensive experience with image processing
- 14 patents filed
- Image management
- Integrated scalable 3i™framework
- 21 CFR
Product vision
- Telepathology
- Any time anywhere access
- Education (CME)
- Image archival
- Integrated workflow
- Improved reporting
Offerings - Software Solutions
Life Sciences Solutions Digital Pathology Solutions
- TissueMine™
- PATHIAM™ for research
- CellMine™
- PATHIAM™ for IVD use (HER2/neu)
- iCRO™
- iScan™ for research
- ProteinMine™
- SIMS™
- 3i Technology
Highlights
- Only software firm globally to get a US - FDA approval
- Only company to provide end-to-end digital pathology solutions in $ 2 Billion Life Sciences industry.
- Software deployed in the top 12 pharma / research / universities across USA
- Over 90% of product engineering happens in India and this includes customer integrations as well.
- Only software that has been developed in way where time in research is optimized and remarkable reduced
- Over 5 years of proven experience in the field of Digital Pathology with strong R & D focus leading to patented algorithms that improve image analysis in the digital pathology segment
Leadership Team
Mohan Uttarwar, CEO
MS EE, MS CS, Florida Tech, EPGC Stanford Roamware, SoftPlus, Dig Tools, Intel, HP, 20+ Years
Vivek Pathak, CFO
MBA, Finance, The Wharton School Cast Iron Systems, Coreon, Cummins, 20+ Years
Dr Sanford Barsky, M.D., Medical Director
Donald A Senhauser Endowed Ohio State University College of Medicine, 20+ Years Chair of Pathology
Steven Barbee, VP Sales
BA, Math, Colorado College Trestle, Zyan Com, Level 3 Com, 15+ Years
Steve Yu, VP Technology Solutions
MS, Comp Science, University of Wisconsin SciMagix, Jamcracker, Aspect, 15+ Years
Himanshu Ubale, VP Engineering
MT, Mech Eng, Indian Institute of Technology Surg Info. Sys., Computervision, TCS, 18+ Years
Greg Loney, VP Instrumentation
MS, Mech Eng, Lehigh University, UCSB Affymetrix, GSI Lumonics, MIT LL, MBA, UCLA, 20+ Years
India Development Center (IDC)
BioImagene India Pvt. Ltd.
4th floor, C-Wing, Godrej Eternia, Shivajinagar, Pune-411005, India.
General Inquiries: +91-20-66096579 / +91-20-65206852 / +91-20-65206405
Fax Number: +91-20-66096573
www.bioimagene.com
Permalink
XML Feeds